M

Member

Speaking in the House of Lords on 10 June 2026

Debate

Food Supplements Purity Criteria (Magnesium L-threonate monohydrate) (England) Regulations 2026

Contribution

I have three questions. First, one consultation respondent highlighted divergences between maximum levels permitted in the EU and those proposed by the FSA. Can the Minister explain the safety rationale for the UK’s chosen parameter, particularly given the point I made about maintaining consumer confidence? Secondly, the Government have opted not to include a statutory review clause because the impact is deemed to be very low. Without a mechanism of that nature, how will the department monitor whether these purity thresholds remain aligned? Finally, since no full impact assessment was produced, what specific guidance or additional resources are being provided to local enforcement bodies to ensure that they can accurately test for the specified purity and contaminant levels?

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.

Partner sites